Long-term trends in incidence, characteristics and prognosis of screen-detected and interval cancers in women participating in the Dutch breast cancer screening programme.

[1]  R. Pijnappel,et al.  The dilemma of recalling well-circumscribed masses in a screening population: A narrative literature review and exploration of Dutch screening practice , 2023, Breast.

[2]  H. Thierens,et al.  Tumour characteristics of screen-detected and interval cancers in the Flemish Breast Cancer Screening Programme: A mammographic breast density study. , 2021, Maturitas.

[3]  N. Houssami,et al.  Meta-analysis of prospective studies evaluating breast cancer detection and interval cancer rates for digital breast tomosynthesis versus mammography population screening. , 2021, European journal of cancer.

[4]  L. Tabár,et al.  Beneficial Effect of Consecutive Screening Mammography Examinations on Mortality from Breast Cancer: A Prospective Study. , 2021, Radiology.

[5]  M. Guindy,et al.  Personalized Screening for Breast Cancer: Rationale, Present Practices, and Future Directions , 2021, Annals of Surgical Oncology.

[6]  E. Morris,et al.  Is It the Era for Personalized Screening? , 2021, Radiologic clinics of North America.

[7]  P. V. van Diest,et al.  Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017 , 2020, International journal of cancer.

[8]  P. Hu,et al.  Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast Cancers , 2020, JAMA network open.

[9]  H. D. de Koning,et al.  Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: A systematic review. , 2020, European journal of cancer.

[10]  K. Czene,et al.  Interval breast cancer is associated with other types of tumors , 2019, Nature Communications.

[11]  D. French,et al.  How do women experience a false-positive test result from breast screening? A systematic review and thematic synthesis of qualitative studies , 2019, British Journal of Cancer.

[12]  H. Putter,et al.  Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial. , 2018, European journal of cancer.

[13]  F. Zanconati,et al.  Interval Breast Cancer Versus Screen‐Detected Cancer: Comparison of Clinicopathologic Characteristics in a Single‐Center Analysis , 2017, Clinical breast cancer.

[14]  Youngjee Choi,et al.  Screening for breast cancer. , 2017, Seminars in oncology.

[15]  Daniel McNeish,et al.  Missing data methods for arbitrary missingness with small samples , 2017 .

[16]  S. Siesling,et al.  Digital vs screen-film mammography in population-based breast cancer screening: performance indicators and tumour characteristics of screen-detected and interval cancers , 2016, British Journal of Cancer.

[17]  V. Tjan-Heijnen,et al.  Characteristics and prognosis of interval cancers after biennial screen-film or full-field digital screening mammography , 2016, Breast Cancer Research and Treatment.

[18]  L. Strobbe,et al.  Type and Extent of Surgery for Screen-Detected and Interval Cancers at Blinded Versus Nonblinded Double-Reading in a Population-Based Screening Mammography Program , 2016, Annals of Surgical Oncology.

[19]  L. Akslen,et al.  Mode of detection: an independent prognostic factor for women with breast cancer , 2016, Journal of medical screening.

[20]  G. Nieuwenhuijzen,et al.  Patterns of Care in the Administration of Neo‐adjuvant Chemotherapy for Breast Cancer. A Population‐Based Study , 2016, The breast journal.

[21]  M. A. Beek,et al.  Two decades of axillary management in breast cancer , 2015, The British journal of surgery.

[22]  Gillian D Sanders,et al.  Benefits and Harms of Breast Cancer Screening: A Systematic Review. , 2015, JAMA.

[23]  S. Zackrisson,et al.  A roller coaster of emotions and sense--coping with the perceived psychosocial consequences of a false-positive screening mammography. , 2014, Journal of clinical nursing.

[24]  Eveline A M Heijnsdijk,et al.  Nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens. , 2013, European journal of cancer.

[25]  J. Groenewoud,et al.  Impact of transition from analog screening mammography to digital screening mammography on screening outcome in The Netherlands: a population-based study. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  Stef van Buuren,et al.  MICE: Multivariate Imputation by Chained Equations in R , 2011 .

[27]  S. Mook,et al.  Independent prognostic value of screen detection in invasive breast cancer. , 2011, Journal of the National Cancer Institute.

[28]  J. Wesseling,et al.  Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands , 2011, Breast Cancer Research and Treatment.

[29]  J. Coebergh,et al.  Breast carcinoma diagnosis, treatment, and prognosis before and after the introduction of mass mammographic screening , 2004, Cancer.

[30]  H. Putter,et al.  Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05) , 2018, Journal of the National Cancer Institute.